HC
VRTX icon

Hara Capital’s Vertex Pharmaceuticals VRTX Stock Holding History

Hara Capital’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.57K Hold
8
– – ﹤0.01% 285
2025
Q4 		$3.63K Hold
8
– – ﹤0.01% 273
2025
Q3 		$3.13K Hold
8
– – ﹤0.01% 270
2025
Q2 		$3.56K Hold
8
– – ﹤0.01% 299
2025
Q1 		$3.88K Sell
8
-8
-50% -$3.73K ﹤0.01% 262
2024
Q4 		$6.44K Buy
16
+8
+100% +$3.71K ﹤0.01% 282
2024
Q3 		$3.72K Buy
+8
New +$3.84K ﹤0.01% 274

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Hara Capital's VRTX Position: Q1 2026 in Review

Hara Capital held its Vertex Pharmaceuticals (VRTX) position steady in Q1 2026 at 8 shares worth $3.57K. The position accounts for ﹤0.01% of the portfolio, ranked #285.

Hara Capital first reported a position in VRTX in Q3 2024 and has held it in 7 quarters since. The position peaked at $6.44K in Q4 2024. 1,687 funds tracked by Wall St. Rank hold VRTX as of Q1 2026.

  • Hara Capital held 8 shares of Vertex Pharmaceuticals worth $3.57K as of Q1 2026.
  • Hara Capital left its Vertex Pharmaceuticals share count unchanged in Q1 2026.
  • Vertex Pharmaceuticals made up ﹤0.01% of Hara Capital's portfolio in Q1 2026, its #285 holding.
  • Hara Capital first reported a position in Vertex Pharmaceuticals in Q3 2024 and has held it in 7 quarters since.
  • Hara Capital's Vertex Pharmaceuticals position peaked at $6.44K in Q4 2024.
  • 1,687 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2026.

Based on Hara Capital's 13F filing for Q1 2026, filed 14 May 2026.